tirzepatide kidneys Tirzepatide, HFpEF, and the Kidney: A Triangular Relationship Requiring Measurement of GFR, Not Guesses Protecting kidneys is a crucial
Description
We sought to investigate the real-world impact of sodiumglucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in individuals with type 1 diabetes in relation to effect on blood glucose levels, adverse events and cardio-renal outcomes
LAS VEGAS GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, according to the findings from a single-center study
Today, GLP 1 therapy is out of reach for many families
GLP1 support tea designed for metabolism, appetite, and digestive balance
